SNYR Analyst Price Targets

Wall Street analyst price targets and consensus rating for SNYR (SNYR).

Price Target Range — 4 Quarters

Analyst Consensus — 3 Analysts

3Buy

Consensus RatingBuy# Analysts3Avg. Consensus PT$7

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Jun 10, 2026	Ascendiant Capital	Edward Woo	PT Cut	Buy	$6→$4
Apr 14, 2026	Ascendiant Capital	Edward Woo	PT Raise	Buy	$5→$6
Feb 2, 2026	Ascendiant Capital	Edward Woo	Initiate	Buy	$5
Nov 14, 2025	Roth Capital	Sean McGowan	PT Cut	Buy	$10→$7
Jan 21, 2025	Roth MKM	Sean McGowan	Initiate	Buy	$10

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Ascendiant Capital Maintains Buy on Synergy CHC, Lowers Price Target to $3.75

Ascendiant Capital analyst Edward Woo maintains Synergy CHC (NASDAQ:SNYR) with a Buy and lowers the price target from $5.5 to $3.75.

Benzinga Newsdesk

PRO
Ascendiant Capital Maintains Buy on Synergy CHC, Raises Price Target to $5.5

Ascendiant Capital analyst Edward Woo maintains Synergy CHC (NASDAQ:SNYR) with a Buy and raises the price target from $5 to $5.5.

Benzinga Newsdesk

This Avalo Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Avi Kapoor

PRO
Ascendiant Capital Initiates Coverage On Synergy CHC with Buy Rating, Announces Price Target of $5

Ascendiant Capital analyst Edward Woo initiates coverage on Synergy CHC (NASDAQ:SNYR) with a Buy rating and announces Price Target of $5.

Benzinga Newsdesk

PRO
Roth Capital Maintains Buy on Synergy CHC, Lowers Price Target to $7

Roth Capital analyst Sean McGowan maintains Synergy CHC (NASDAQ:SNYR) with a Buy and lowers the price target from $10 to $7.

Benzinga Newsdesk

PRO
Roth MKM Initiates Coverage On Synergy CHC with Buy Rating, Announces Price Target of $10

Roth MKM analyst Sean McGowan initiates coverage on Synergy CHC (NASDAQ:SNYR) with a Buy rating and announces Price Target of $10.

Benzinga Newsdesk

SNYR

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

SNYR Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Ascendiant Capital Maintains Buy on Synergy CHC, Lowers Price Target to $3.75

PRO
Ascendiant Capital Maintains Buy on Synergy CHC, Raises Price Target to $5.5

This Avalo Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

PRO
Ascendiant Capital Initiates Coverage On Synergy CHC with Buy Rating, Announces Price Target of $5

PRO
Roth Capital Maintains Buy on Synergy CHC, Lowers Price Target to $7

PRO
Roth MKM Initiates Coverage On Synergy CHC with Buy Rating, Announces Price Target of $10

SNYR

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

SNYR Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROAscendiant Capital Maintains Buy on Synergy CHC, Lowers Price Target to $3.75

PROAscendiant Capital Maintains Buy on Synergy CHC, Raises Price Target to $5.5

This Avalo Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

PROAscendiant Capital Initiates Coverage On Synergy CHC with Buy Rating, Announces Price Target of $5

PRORoth Capital Maintains Buy on Synergy CHC, Lowers Price Target to $7

PRORoth MKM Initiates Coverage On Synergy CHC with Buy Rating, Announces Price Target of $10

PRO
Ascendiant Capital Maintains Buy on Synergy CHC, Lowers Price Target to $3.75

PRO
Ascendiant Capital Maintains Buy on Synergy CHC, Raises Price Target to $5.5

PRO
Ascendiant Capital Initiates Coverage On Synergy CHC with Buy Rating, Announces Price Target of $5

PRO
Roth Capital Maintains Buy on Synergy CHC, Lowers Price Target to $7

PRO
Roth MKM Initiates Coverage On Synergy CHC with Buy Rating, Announces Price Target of $10